Kester Capital

Frontier Medical Group scoops top honour at BVCA Management Team Awards

13 May 2016

Frontier Medical Group, the specialist medical device manufacturer, has been named Wales Mid-Market Team of the Year at the British Private Equity & Venture Capital Association (BVCA) Management Team Awards 2016.

The BVCA Awards, which are held in association with Grant Thornton, seek to reward the best in UK business backed by private equity and venture capital, and celebrate the contribution made by those firms to the wider economy.

Now in their eighth year, the 2016 event saw nominees and their guests gather for a gala dinner in Bath Assembly Rooms on the 12th May, and Frontier Medical Group was recognised for the first time following the buyout backed by Kester Capital in December 2013.

The company, which was established in 1966, manufactures a range of cost and clinically effective products for use in community and hospital care, and has enjoyed strong growth in the last few years under its new ownership.

Simon Jackson, Managing Director at Frontier Medical Group said: “This award is a real honour and it’s a testament to the hard work of each and every one of our employees and the quality of the products we provide. In the time since the deal we’ve been able to make a significant investment right across our infrastructure, not only in terms of manufacturing and growing our Export markets, but in our staff as well, and that’s something we as a company are very proud of. We believe it is a significant factor in our ongoing success.”

Commenting on Frontier Medical Group’s entry Richard Young, Director at BVCA said: “Simon Jackson has led a new team at Frontier since the acquisition in 2013, which has transformed the business in terms of sales and marketing strategy, new product development, production efficiency and development of new export markets. The transformation has been hugely impressive.”

Frontier have worked extensively with clinicians in the NHS to develop the Repose® range of pressure area care products, which today are the most widely used pressure area care products in the UK. Over 3.5 million people have used Repose® products in the UK alone. 

The firm’s range of disposal units for clinical sharps, Sharpsafe®, are the world’s first bespoke sharps containers and they have received numerous design awards since they were first marketed in 1980. They are also the UK’s market leader in providing products to Harm Reduction services through its eXchange™ brands.

For more information visit or follow @FMG_Group on Twitter.

Contact us:

Kester Capital:
Cameron Crockett/Jeniv Shah             +44 20 3747 5700

Frontier Medical:
Simon Jackson/Matthew Bambery       +44 1495 235 800

Media Contact:
Andrew McClenaghan                         +44 20 7887 2648

About Kester Capital

Kester Capital is a mid-market UK private equity firm investing in businesses with an enterprise value of £10-50 million. It was established in 2007 as Greenhill Capital Partners Europe, the European private equity arm of Greenhill & Co.

About Frontier Medical

Frontier, based in Blackwood, South Wales, was incorporated in 1966 and is now a market leading UK manufacturer and provider of a range of medical devices to healthcare professionals and end users in both the UK and internationally. Frontier’s products contribute greatly to the safety and wellbeing of their users, specifically in Pressure Area Care, Infection Control and Harm Reduction. Its main product lines are:

  • Repose® - A range of pressure area care devices (e.g mattresses, cushions, foot protectors) used in both the treatment and prevention of pressure ulcers;
  • Sharpsafe® - A range of containers for the safe disposal of clinical sharps which have evolved in line with healthcare requirements and legislation; and
  • eXchange - A range of products developed to meet the growing demand for specialised equipment and paraphernalia for the needle exchange and harm reduction programmes operated within the UK.